Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

North Dartmouth, Massachusetts 02747


Purpose:

The objective of this trial is to assess the pulmonary safety of 2 inhaled doses of Staccato Loxapine within a day.


Study summary:

The planned study is a multiple dose, double-blind, placebo-controlled, randomized, 2-sequence, 2-period crossover study investigating pulmonary safety in healthy volunteers.


Criteria:

Inclusion Criteria: - nonsmoker subjects in good general health with normal spirometry at screening AND baseline Exclusion Criteria: - history of asthma, COPD, or any other acute or chronic pulmonary disease or bronchodilator use


NCT ID:

NCT00789360


Primary Contact:

Principal Investigator
David S. Miller, MD
Northeast Medical Research, North Dartmouth, MA


Backup Contact:

N/A


Location Contact:

North Dartmouth, Massachusetts 02747
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.